AlphaGrep UK Ltd’s Hims & Hers Health HIMS Stock Holding History

AlphaGrep UK Ltd’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Buy	13,400 +6,590	+97%	+$156K	0.08%	549
2025 Q4	$221K	Buy	+6,810	New	+$292K	0.07%	586

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Defiance ETFs New York $6.98B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AlphaGrep UK Ltd's HIMS Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Hims & Hers Health (HIMS) stake by 97% in Q1 2026, buying an estimated $156K and bringing the position to 13,400 shares worth $278K. The position accounts for 0.08% of the portfolio, ranked #549.

AlphaGrep UK Ltd first reported a position in HIMS in Q4 2025 and has held it in 2 quarters since. 435 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

AlphaGrep UK Ltd held 13,400 shares of Hims & Hers Health worth $278K as of Q1 2026.
AlphaGrep UK Ltd bought 6,590 Hims & Hers Health shares in Q1 2026, an estimated $156K.
Hims & Hers Health made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #549 holding.
AlphaGrep UK Ltd first reported a position in Hims & Hers Health in Q4 2025 and has held it in 2 quarters since.
435 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.